Cancer, Fda | featured news

FDA approves new targeted breast cancer drug


The Food and Drug Administration says it has approved a new form of a best-selling breast cancer drug that targets tumor cells while sparing healthy ones. The drug Kadcyla (kad-SY'-luh) from Roche combines the established drug Herceptin with a powerful chemotherapy drug and a third chemical linking the medicines together. The chemical keeps the cocktail intact until it binds to a cancer cell, delivering a double-shot of anti-tumor poison.


FDA Did the Right Thing in Pulling Avastin for Breast Cancer

FDA Did the Right Thing in Pulling Avastin for Breast Cancer

If you want the FDA to approve more innovative, new drugs based on promising but early clinical results, you have to give the FDA a way to revoke those approvals later on, should larger trials prove that those drugs aren't as safe or effective as they first seemed. This is why the FDA should be congratulated for the way it has handled the Avastin breast cancer saga, and why I hope we will see the FDA handle more cases like this one, not less.


FDA questions safety of experimental diabetes drug

Federal health regulators have concerns about bladder and breast cancer seen in patients taking an experimental diabetes pill from Bristol-Myers ...


FDA to hear appeal on breast cancer drug Avastin

The best-selling cancer drug in the world comes under federal scrutiny as drugmaker Roche makes a last-ditch effort to keep Avastin approved ...


FDA wants more sunscreen protections

FDA wants more sunscreen protections

Federal regulators will require sunscreen manufacturers to test their products' effectiveness against sun rays that pose the greatest risk of skin cancer. Under new rules published Tuesday, they also will have to follow stricter guidelines when describing how well their products block ultraviolet B rays....


Avastin Loses Approval for Breast Cancer

The FDA said it is recommending that Roche's Avastin no longer be approved for treatment of breast cancer.


F.D.A. Approves Vaccine for Prostate Cancer

F.D.A. Approves Vaccine for Prostate Cancer

The treatment is the first to use a so-called cancer vaccine that trains the body’s immune system to fight the disease.


FDA approves cancer drug for dogs

The U.S. Food and Drug Administration has approved the first drug made specifically to treat cancer in dogs.


Subscribe to this RSS topic: Syndicate content